What's breaking now, across thousands of outlets.
The U.S. Food and Drug Administration has approved Lisraya (brepocitinib) tablets as the first oral treatment for dermatomyositis in adults.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
(MedPage Today) -- A diagnosis of myocardial infarction (MI) now falls into one of three types: primary, secondary, or procedure-related, based on the new Fifth Universal Definition.
Nollywood has been plunged into mourning once again following the death of actress Atinuke Kareem, who passed away after battling breast cancer.
The Foundation for Democracy in Africa (FDA) has welcomed the decision by the Director-General of the Department of State Services (DSS), Oluwatosin Adeola Ajayi, to appeal to the Federal High
As the 18th World Congress on Public Health convenes in Cape Town, the public health community has an opportunity to confront the escalating health impacts of the climate crisis and lead Africa’s…
Public comments for the latest OPPS proposed rule saw several major hospital groups all but threatening a court showdown over CMS' planned policy changes.
(MedPage Today) -- Medical students are conducting more research than ever before, but does this make them better doctors or improve the field of medicine?
